Humira vs Vtama

Humira: An injected biologic for moderate to severe plaque psoriasis. It blocks TNF, one of the main inflammation signals behind psoriasis, and is usually given as a shot under the skin every other week. Vtama: A once-daily steroid-free cream for plaque psoriasis. It can be used anywhere on the body, including the face and skin folds, and some people stay clear for months after stopping.

Reviewed by Dr. Schwarz, Board-Certified Dermatologist
A silver and dark pink autoinjector pen labeled Humira lying on a white backgroundVtama — Header Image

Which one is right for you?

Choose Humira if…

Choose for moderate to severe psoriasis or hidradenitis suppurativa — the first approved biologic for HS, now with cheaper biosimilars.

  • Psoriasis or HS not controlled by creams or tablets
  • Joint pain from psoriatic arthritis too
  • No active TB or serious infections

Choose Vtama if…

Choose for psoriasis or eczema anywhere on the body when you want a once-daily non-steroid with no time limit.

  • Psoriasis on the face or folds
  • You want to avoid steroid thinning
  • Once-daily use suits you
Fine together

Can you take them together?

Vtama can be used on remaining plaques while on Humira. It does not interact with the biologic.

At a glance

● Humira
● Vtama
Type
Biologic injection (adalimumab, TNF blocker)
Topical AhR agonist (tapinarof 1%)
What it does
Blocks TNF, a main inflammation signal
Calms inflammation and restores the skin barrier
Best for
Psoriasis, hidradenitis suppurativa, psoriatic arthritis
Plaque psoriasis and eczema, including face and folds
Prescription
Yes
Yes
Form
Injection under the skin
Cream
How often
Every other week (weekly for HS)
Once daily
Course length
Ongoing
No time limit
Time to results
12–16 weeks
8–12 weeks
Main side effect
Injection-site reactions; infections
Folliculitis
Blood tests
TB and hepatitis tests before starting
None
Pregnancy
Check with your clinician
Check with your clinician
Cost
High; biosimilars available
High; brand only

What it treats

Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.

Evidence level
Humira
Vtama
Strong evidenceMost established uses
An inflamed lump in the armpit on fair skin. The skin over it is swollen, shiny and red, with a pair of small blackhead-like openings in the skin beside it.

Hidradenitis Suppurativa

The first approved treatment.
Two thick, sharply bordered plaques on a knee on fair light skin. They are salmon-pink to red with loose silvery-white scale on top.

Psoriasis

Clears moderate to severe plaques.
Psoriatic Arthritis on light skin.

Psoriatic Arthritis

Reduces joint damage.
Two thick, sharply bordered plaques on a knee on fair light skin. They are salmon-pink to red with loose silvery-white scale on top.

Psoriasis

Clears plaques without steroids.
Extreme close-up of light skin in an active eczema flare, too close to tell which part of the body it is. Blotchy pink-red inflammation covers the whole frame with no clear edge, with small raised bumps, fine dry scale and a few fresh scratch marks.

Eczema

Reduces itch and redness.
Little evidence
—
Redness and fine superficial vessels across a light-skinned cheek and nose.

Rosacea

Not studied for rosacea.
Not effective
Extreme close-up of light skin in an active eczema flare, too close to tell which part of the body it is. Blotchy pink-red inflammation covers the whole frame with no clear edge, with small raised bumps, fine dry scale and a few fresh scratch marks.

Eczema

Doesn't target eczema inflammation.
—
Can make it worse
AI-generated educational illustration of Melanoma: 1. Melanoma Header — Light Skin; Lighter skin. Not a clinical photograph.

Melanoma

May slightly raise skin cancer risk.
Inflamed acne on light skin. The spots sit in a patch of pink, and the ring of redness around each one is easy to see. A few have a yellow-white head, and the skin between them is dry and flaking.

Acne

Folliculitis and acne are possible side effects.
How it works

Humira

Humira. Adalimumab blocks the inflammatory messenger TNF. 1. Binds TNF: Captures an immune messenger that promotes inflammation. 2. Reduces inflammatory signaling: TNF has less ability to activate its receptors. 3. Lets inflamed skin settle: Conditions such as psoriasis can improve over time.
Open full-size diagram
Diagram explanation and sources

Binds TNF: Captures an immune messenger that promotes inflammation. Reduces inflammatory signaling: TNF has less ability to activate its receptors. Lets inflamed skin settle: Conditions such as psoriasis can improve over time.

Adalimumab binds TNF-alpha and inhibits its interaction with p55/p75 TNF receptors. This image focuses on skin inflammation; Humira also has other indications.

Source 1

Vtama

Vtama. Tapinarof activates a skin-regulating receptor. 1. Activates AhR: Binds a receptor that helps regulate skin-cell behavior. 2. May rebalance inflammation: Changes in immune signaling may help calm skin. 3. May support the skin barrier: Changes in barrier proteins may help skin function.
Open full-size diagram
Diagram explanation and sources

Activates AhR: Binds a receptor that helps regulate skin-cell behavior. May rebalance inflammation: Changes in immune signaling may help calm skin. May support the skin barrier: Changes in barrier proteins may help skin function.

Tapinarof is an AhR agonist; the specific therapeutic mechanisms are unknown. Anti-inflammatory and barrier effects are proposed from experimental evidence and are explicitly qualified.

Source 1 · Source 2

How you take it

Treatment plan

Adults are not dosed by body weight. You start with a larger loading dose to get levels up fast, then settle into an every-other-week rhythm.

Starting dose: 80 mg on day one, as one 80 mg injection or two 40 mg injections at different spots.

One week later: 40 mg.

Usual dose: 40 mg every other week, the same day of the week each time.

If it stops working: Some people move to weekly injections, others switch drugs. The prescriber's call.

Other conditions: Hidradenitis suppurativa uses a heavier loading dose and weekly maintenance, so do not assume a friend's schedule matches yours.

How long: Long term, with no set course length. It continues while it works and is tolerated.

When to Apply: Once a day, at whatever time you will remember. A thin layer over the plaques, rubbed in. It can go on the face, eyelids, armpits, groin and under the breasts, which sets it apart from a steroid. Wash your hands afterwards unless your hands are being treated.

How to Start: Once daily from day one, on every plaque you want treated. No ramp-up, and no cap on how much of the body can be covered, so it does not have to be rationed the way a strong steroid does.

If It Irritates: Small red bumps around hair follicles are the most common problem and usually appear in the first few weeks. Most are not infection and often settle without stopping. Stinging or a rash where you applied it is the other pattern, and that one is worth showing your doctor, because a true contact allergy means stopping.

If It’s Not Working: There is one strength, so there is nothing to increase. Give it a full twelve weeks. If plaques are still thick then, the conversation is about adding something else, phototherapy, or moving to a tablet or injection.

When to take it

Any time of day, but pick a set day of the week and keep to it. Every other week is easy to lose track of, so set a phone reminder on day one.

Take the pen or syringe out of the fridge 15 to 30 minutes before injecting. Cold liquid stings more. Do not warm it in the microwave or hot water.

Inject into the front of the thigh or the belly, at least two inches from the navel. Rotate the spot each time, and avoid skin that is bruised, red, hard, tender or scarred. Never inject through a plaque. A nurse or pharmacist should train you in person for the first dose. Used pens go in a sharps container, never the household bin.

Not covered in this guide yet
If you miss a dose

Inject as soon as you remember, then return to your original schedule rather than shifting future doses. Never inject two doses to catch up. If you have missed more than one dose, call the prescriber before restarting — long gaps can blunt how well it works.

Not covered in this guide yet
Monitoring

Everyone is screened for tuberculosis before the first dose — a skin test or TB blood test, often with a chest X-ray. TNF blockers can wake a dormant TB infection, so a positive screen is treated first and adalimumab waits until that treatment is under way. Testing is often repeated yearly, or sooner if you live somewhere TB is common.

Hepatitis B and C are checked too, because hepatitis B can reactivate when the immune signal is blocked.

After that there is no fixed blood test schedule like methotrexate's. Many doctors check a blood count and liver tests occasionally. Most monitoring is clinical — how the skin looks, and whether you are getting more infections than usual.

Skin should be checked periodically, because TNF blockers are linked to a small increase in skin cancer. The label also carries a boxed warning about serious infections and about lymphoma and other cancers, based mostly on rare cases in children and young adults. The absolute risk is low, but it is why this prescription gets regular review.

No blood tests are required. There is nothing to check on a lab report, which is one of the practical arguments for a topical over a tablet.

Monitoring is a look at the skin and a conversation, usually at about twelve weeks. Two things get asked about: folliculitis, and whether it is a few bumps or enough to be a problem; and whether the treated skin has become itchy and inflamed in a new way, which points to contact dermatitis rather than psoriasis.

Long term there is no organ risk to track and no skin thinning to watch for, so there is no maximum duration. What is genuinely not known yet is what many years of continuous use looks like, because the drug is recent. A common pattern is to treat until clear, stop, and restart when plaques come back.

When you’ll see results

Approximate windows, not promises.

● Humira
● Vtama
First few minutes

First few minutesThe injection: A sting for a few seconds. Injection site reactions, if they happen, show up in the first weeks.

First few minutesApplying it: A thin layer once a day on the plaques.

Weeks 1 to 4

Weeks 1 to 4Starting: Itching often eases before the plaques look different, and some people see the scale thin early.

Weeks 1 to 4Starting: Scale and roughness ease before the redness does, often by week four. Folliculitis shows up now if it is going to, usually small tender bumps in hair-bearing areas.

Weeks 4 to 12

Weeks 4 to 12Working: Plaques flatten, scale lifts and redness fades from the middle outward. Most of the visible change happens here. Psoriatic arthritis improves on a similar timeline, and hidradenitis suppurativa settles to fewer painful lumps on its own heavier schedule.

Week 16

Week 16Judge it here: The point the trials measured. Most people reached at least a 75 percent improvement in skin involvement and severity, and a smaller share cleared almost completely.

Months 6 to 12

Months 6 to 12Nails: The slowest, because a nail takes months to grow out. Pitting and lifting improve well after the skin has settled.

After the first year

After the first yearLong term: Most people who respond keep responding.

Weeks 4 to 8

Weeks 4 to 8Working: Plaques flatten and shrink, and color fades from red toward pink or brown.

Weeks 8 to 12

Weeks 8 to 12Judge it here: Trials measured their main result at twelve weeks, and many people were still improving then. A meaningful minority reached clear or almost clear skin — a realistic target, not a promise.

After stopping

After stoppingRemission: Unlike a steroid, it does not usually rebound. People who cleared completely often stayed clear for months before restarting.

Side effects

Sorted by what to do about them.

Humira

Vtama

Common
Common
  • Injection-site redness or itch
  • Cold-like infections
  • Headache
Common
  • Folliculitis (small red bumps at hair follicles)
  • Itch, headache
Tell your doctor
Tell your doctor
  • Persistent cough, weight loss or night sweats
  • New rash or psoriasis on palms and soles
Tell your doctor
  • Acne-like spots that persist
Stop and get care
Stop and get care
  • Fever with signs of serious infection
  • Swelling of face or throat
Stop and get care
  • Spreading painful infection

Safety and who should avoid it

Pregnancy
Use care
Often continued with planning; ask the doctor managing your pregnancy.
Ask first
Discuss with your clinician.
Breastfeeding
Use care
Generally considered compatible; confirm with your clinician.
Ask first
Discuss with your clinician.
Children
OK
Approved in children for several conditions.
2 and older
Approved from 2 for eczema.
Monitoring
Sometimes
TB and hepatitis B tests before starting.
None
Review at 12 weeks.
Key interactions
Check
Avoid live vaccines; other biologics.
None known
—
Other cautions
Avoid
Active infection, TB, heart failure, multiple sclerosis.
Use care
Folliculitis-prone skin.

Cost and getting it

Getting it and cost

The list price is very high, tens of thousands of dollars a year. Almost nobody pays that. What you pay depends on your insurance, and getting there takes paperwork.

Prior authorization is close to universal. Most plans require you to have tried and failed something cheaper first — phototherapy, methotrexate or another systemic drug — and they want records to prove it.

Biosimilars changed the picture. Several have been sold in the United States since 2023, some at much lower list prices. Which one you get is usually decided by your plan's formulary, not your dermatologist, and plans switch year to year. A switch is a paperwork event, not a medical downgrade, though you may need retraining on a different pen.

Manufacturer copay cards can bring the cost down to very little with commercial insurance. By law they cannot be used with Medicare or Medicaid. For those plans, or with no insurance, manufacturer and foundation assistance programs are the usual route, and their rules change often.

Brand only, with no generic. It is one of the more expensive topicals for psoriasis and costs far more than a generic steroid or generic calcipotriene.

Coverage varies and prior authorization is common; plans frequently want to see a topical steroid, and often a vitamin D analog, tried first. Manufacturer copay cards exist and the terms change, so check the current one.

Because a tube covers only so much, cost climbs quickly with widespread psoriasis, which is one of the main reasons people end up on a tablet or injection instead.

When you stop

Comes back?
Psoriasis and HS usually return over months.
Some people stay clear for months after stopping.
Taper needed?
No.
No.
After the last dose
Restarting can work, but some people respond less well the second time.
Restart if plaques return.

Common questions

Humira:What does biologic actually mean?

A large protein grown in living cells rather than a factory chemical. That is why it is injected, and why it lives in the fridge.

Humira:Does the injection hurt?

A sharp sting for a few seconds. Letting it warm to room temperature first makes a real difference, and citrate-free versions sting less than the original.

Humira:How long before I know if it is working?

Some change by 4 weeks, and about 16 weeks before you judge it fairly. If nothing has happened by then, talk about switching.

Humira:Can I still have vaccines?

Yes, apart from live ones. The flu shot, COVID, pneumonia vaccines and Shingrix are fine and usually recommended. Have live vaccines before you start.

Humira:What do I do if I catch a cold or need antibiotics?

A simple cold is usually not a reason to skip a dose. Anything with a fever, or needing antibiotics, should be checked with the prescriber first.

Humira:Is a biosimilar as good as Humira?

It must be shown to have no clinically meaningful difference from the original. The pen changes; what is inside does the same job.

Vtama:Is it a steroid?

No. It works on a different switch inside the skin cell, the aryl hydrocarbon receptor. That is why there is no time limit and no skin thinning.

Vtama:Can I put it on my face?

Yes — approved for the face and skin folds, one of its main advantages over a steroid.

Vtama:What are the little bumps I am getting?

Most likely folliculitis — small red bumps around hair follicles where you applied it. The most common side effect in the trials, at roughly one in five people, usually mild, and most carried on.

Vtama:How long before I know if it works?

Give it twelve weeks. Some change usually shows by four.

Vtama:Can I stop once I am clear?

That is a normal way to use it. In the long-term study, many who cleared completely stayed clear for months, then restarted when plaques returned.

Vtama:Does it work for eczema too?

Yes, it is also approved for atopic dermatitis, in adults and in children from age two.

Dermapedia on YouTube